Zigui-Changqi Decoction against Premature Ovarian Insufficiency by Moderating Autophagy via EGFR/ERBB2/IL6/AKT1 Signals
Gynecologic and Obstetric Investigation · 2025
DOI: 10.1159/000545205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Lijuan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, YunNan Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Yunnan University of Chinese M…. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Autophagy, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Autophagy defect has been detected in premature ovarian insufficiency (POI) patients.
Aim
The aim of this study was to evaluate the efficacy and explore the mechanism of Zigui-Changqi decoction (ZCD) in the treatment of POI. Materials and Methods: Rat model of POI was established to evaluate the efficacy of ZCD on serum hormone levels, ovarian index, and ovarian cell apoptosis. The effect of ZCD on the autophagy of granulosa cell was assessed. Network pharmacology was used to predict potential targets of ZCD against POI.
Results
ZCD attenuated tripterygium glycoside-induced damage to ovarian tissues in rats by improving ovarian index, moderating serum hormone levels, inhibiting ovarian cell apoptosis, and increasing the number of ovarian stromal cells. ZCD moderated the expression of autophagy-related markers, including BECN1, p62, and LC3. Through network pharmacological analysis, the predicted hub genes were EGFR, ERBB2, AKT1, IL6, PTEN, and TP53. After molecular docking and detection of cell expression levels, EGFR, ERBB2, AKT1, and IL6 were inhibited by ZCD, as well as mechanistic target of rapamycin complex 1.
Conclusion
ZCD can ameliorate POI, maybe by moderating autophagy via EGFR/ERBB2/IL6/AKT1 signals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, YunNan Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Reproductive Medicine, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China.
- The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
- The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
- Ethics Committee, YunNan Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.
Zitieren
APA
Jiang, L., Wang, Y., Kong, S., Qian, Y., Chen, D., Shao, M., Zhai, M., & Jiang, L. (2025). Zigui-Changqi Decoction against Premature Ovarian Insufficiency by Moderating Autophagy via EGFR/ERBB2/IL6/AKT1 Signals. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000545205
Vancouver
Jiang L, Wang Y, Kong S, Qian Y, Chen D, Shao M, et al. Zigui-Changqi Decoction against Premature Ovarian Insufficiency by Moderating Autophagy via EGFR/ERBB2/IL6/AKT1 Signals. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000545205
BibTeX
@article{Jiang2025,
author = {Jiang, Lijuan and Wang, Yiwen and Kong, Sai and Qian, Yanping and Chen, Dongqiong and Shao, Mengqiu and Zhai, Manyin and Jiang, Lijuan},
title = {Zigui-Changqi Decoction against Premature Ovarian Insufficiency by Moderating Autophagy via EGFR/ERBB2/IL6/AKT1 Signals},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
doi = {10.1159/000545205}
}
EUVIMED